© 2021 FM Global. All rights reserved.
STAY IN TOUCH
KNOLL
Knoll’s iconic designs can be found in TV shows, movies and Fortune 100 boardrooms.
WATCH VIDEO
United Therapeutics
At FM Global, we partner with some of the most innovative companies in the world.
MORE FOR YOU
United Therapeutics’ Dinutuximab-Dedicated Oncology Medical & Analytical Laboratory in Silver Spring, Maryland, USA, features a bold cylindrical design and LED dome.
Vice President of Real Estate and Construction, United Therapeutics
AVI HALPERT
When we start a project, we know we’re going to have an impact
on people’s lives. That’s the passion that drives this company.
And it’s obvious that FM Global is equally passionate about
what it brings in terms of building safety.
When you make life-sustaining medications, you can never run out.
FROM FM GLOBAL'S 2020 ANNUAL REPORT
People’s lives depend on the resilience of your manufacturing plants, your warehouses and your research facilities.
When Chris Donnelly joined United Therapeutics in 2012, she was keenly aware of the importance of her role as head of enterprise risk management. And she knew just the insurance partner she wanted.
Contact an FM Global representative.
Connect with us
Keep me informed
Subscribe to your choice of
FM Global’s eNewsletters.
UNITED THERAPEUTICS
CORPORATION
Breathing easy
“We strive to be one of the most resilient, socially responsible biotechnology companies in the world,” Donnelly explains. “One of the ways you do that is to partner with the best companies and that’s why we chose FM Global, because there is no one better in commercial property insurance.”
By 2012, United Therapeutics had come a long way.
It had emerged as the leader in the treatment of pulmonary arterial hypertension (PAH), a rare and life-threatening lung disease. Driven by founder Martine Rothblatt, whose daughter’s diagnosis with PAH inspired the company’s formation, United Therapeutics continues to push the boundaries of what’s possible in its quest to treat and ultimately cure PAH.
Its cutting-edge research, innovative drugs and pioneering therapies have helped thousands of people with PAH lead active, productive lives.
Since the beginning, United Therapeutics has understood its importance to the patients who rely on its medications and treatments. The company has vowed to have a two-year supply of every drug it produces on hand and ready for distribution at all times. With that as a backdrop, Donnelly knew that she had the support she needed to redefine resilience as an enterprisewide effort to protect those drugs and the company’s infrastructure.
“At United Therapeutics, we always choose to do the right thing, even if it’s not the least expensive thing,” she says.
The first project with FM Global, she recalls, was to retrofit an existing warehouse with sprinklers. The capital expenditure was significant, but the risk to United Therapeutics’ patients was just too great to leave the building unprotected.
That philosophy affects everything United Therapeutics does. Its buildings are designed to create inspiring work environments for its 900 employees, but also have a minimal impact on the environment. The shining example is its new Unisphere building in downtown Silver Spring, Maryland, USA, which generates more energy than it consumes.
“Any time we have an idea for a new project, FM Global is always at the table with us,” explains Avi Halpert, United Therapeutics’ vice president of real estate and construction. “We are always pushing
the boundaries of building and design. FM Global has such depth and expertise, we’re able to do it
with confidence.”
Above all, United Therapeutics is driven by its mission to make life better for people with respiratory diseases. In Jacksonville, Florida, USA, United Therapeutics teamed with the Mayo Clinic to build
a facility that reassesses donated organs to help transplant centers determine suitability for transplantation.
The building created unique challenges. Windows were a major feature in its cutting-edge architecture. FM Global helped ensure the building was not only visually pleasing, but was also
able to withstand high winds in the hurricane-prone area.
It‘s clear that innovative ideas won’t stop at United Therapeutics as the company continues to redefine resilience and success.
The company is experimenting with drones to deliver organs for transplant more quickly and recently announced plans for a facility that will create artificial lungs using 3-D printing technology. The hope is that manufactured lungs and other organs will create an unlimited transplant supply, curing PAH and other diseases.
And whatever United Therapeutics comes up with, FM Global will be there to help.
“When we start a project, we know we’re going to have an impact on people’s lives,” Halpert concludes. “That’s the passion that drives this company. And it’s obvious that FM Global is equally passionate about what it brings in terms of building safety.”
Enterprise Risk Manager, United Therapeutics
CHRIS DONNELLY
We strive to be one of the most resilient,
socially responsible biotechnology companies
in the world.
READ MORE
Watch: The Path to Transforming the Treatment of Rare Diseases.
Download UNITED THERAPEUTICS CORPORATION PROFILE
Find out how Disney’s resilience
helps make its theme parks the happiest places on earth.
READ MORE
DISNEY
© 2021 FM Global. All rights reserved.
Keep me informed
Subscribe to your choice of
FM Global’s monthly eNewsletters.
Contact an FM Global representative.
Connect with us
STAY IN TOUCH
See what’s available through
FM Global’s Learning Center.
READ MORE
FM GLOBAL LEARNING CENTER
Read how a Research Campus trip
inspired Land O’Lakes.
READ MORE
Hello flood
Learn more about the
FM Global Research Campus.
READ MORE
FM GLOBAL RESEARCH CAMPUS
Learn more about FM Global’s clients,
products and services.
MORE FOR YOU
Cookie Notice